{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:20:26Z","timestamp":1795123226348,"version":"4.10.3"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"name":"Hologic","id":[{"id":"https:\/\/ror.org\/02td4ph55","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To compare changes in symptom severity and health-related quality of life (HRQOL) after laparoscopic radiofrequency ablation (RFA) and myomectomy for the treatment of uterine leiomyomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>The ULTRA (Uterine Leiomyoma Treatment With Radiofrequency Ablation) study is a multicenter prospective cohort study of premenopausal women with symptomatic uterine leiomyomas undergoing laparoscopic RFA or myomectomy. Participants completed validated patient-reported outcome measures, including the UFS-QOL (Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire), at baseline and at 6-month intervals for up to 24 months after treatment. Changes from baseline in symptom severity and HRQOL domains were evaluated with propensity-weighted repeated-measures models to account for potential treatment selection bias and within-subject correlation over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 401 participants were included (237 with RFA, 164 with myomectomy) with a mean\u00b1SD age of 39.2\u00b16.9 years; 53% (n=210) identified as Black. Three hundred eighty-six participants provided follow-up outcome measures. Participants had a median of two leiomyomas (interquartile range 1\u201315) and substantial baseline symptom burden, with a mean\u00b1SD SSS (Symptom Severity Scale) score of 61\u00b123 and HRQOL score of 41\u00b126). Both treatment groups demonstrated significant and sustained improvements in symptoms and HRQOL over the 24-month follow-up period. In propensity-weighted models, the myomectomy group experienced greater reductions in SSS (\u221233.0 vs \u221227.7, difference \u22125.27,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.028) and greater improvements in HRQOL (34.92 vs 28.29, difference \u22126.62,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.011) compared with RFA. These differences were below the threshold for minimal clinically important changes in SSS (10 points) and HRQOL (20 points). At interim 6-month assessments, myomectomy showed modestly greater improvements in functional subdomains such as activities, control, and self-consciousness; however, these differences diminished and were not observed at 24 months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Both laparoscopic RFA and myomectomy significantly improve leiomyoma-related symptoms and HRQOL over 2 years. Although myomectomy demonstrates slightly greater improvements in some domains, overall differences between treatments are small and do not exceed the threshold change scores for clinically important differences at 2 years of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT0210094.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006432","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:00:10Z","timestamp":1790107210000},"page":"712-722","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of Laparoscopic Radiofrequency Ablation of Uterine Leiomyomas Compared With Myomectomy on Symptoms and Health-Related Quality of Life"],"prefix":"10.1097","volume":"148","author":[{"given":"Antoinette","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schembri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Parvataneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Elaine","family":"Waetjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naghmeh","family":"Salamat-Saberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Kho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Sobolewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyini","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa L.","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"R1-20261119","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2013.08.008","article-title":"The health disparities of uterine fibroid tumors for African American women: a public health issue","volume":"210","author":"Eltoukhi","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20261119","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in Black and White women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20261119","doi-asserted-by":"crossref","first-page":"492.e1","DOI":"10.1016\/j.ajog.2011.07.008","article-title":"Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends","volume":"205","author":"Wechter","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R4-20261119","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/AOG.0000000000002331","article-title":"Comparative effectiveness of uterine leiomyoma procedures using a large insurance claims database","volume":"130","author":"Borah","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R5-20261119","doi-asserted-by":"crossref","first-page":"95.e1","DOI":"10.1016\/j.ajog.2018.05.004","article-title":"The Comparing Options for Management: Patient-Centered Results for Uterine Fibroids (COMPARE-UF) registry: rationale and design","volume":"219","author":"Stewart","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20261119","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/GME.0000000000001043","article-title":"Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study","volume":"25","author":"Laughlin-Tommaso","year":"2018","journal-title":"Menopause"},{"key":"R7-20261119","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/AOG.0000000000004401","article-title":"Management of symptomatic uterine leiomyomas. ACOG Practice Bulletin No. 228. American College of Obstetricians & Gynecologists","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R8-20261119","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1477-7525-11-139","article-title":"Radiofrequency volumetric thermal ablation of fibroids: a prospective, clinical analysis of two years' outcome from the halt trial","volume":"11","author":"Guido","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"R9-20261119","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/AOG.0b013e31828b7962","article-title":"Outpatient procedure for the treatment and relief of symptomatic uterine myomas","volume":"121","author":"Chudnoff","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R10-20261119","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jmig.2022.01.009","article-title":"Clinical and patient reported outcomes of pre- and postsurgical treatment of symptomatic uterine leiomyomas: a 12-month follow-up review of TRUST, a surgical randomized clinical trial comparing laparoscopic radiofrequency ablation and myomectomy","volume":"29","author":"Yu","year":"2022","journal-title":"J Minim Invasive Gynecol"},{"key":"R11-20261119","doi-asserted-by":"crossref","first-page":"345.e1","DOI":"10.1016\/j.ajog.2019.09.052","article-title":"Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF fibroid registry","volume":"222","author":"Laughlin-Tommaso","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R12-20261119","doi-asserted-by":"crossref","first-page":"275.e1","DOI":"10.1016\/j.ajog.2023.05.020","article-title":"Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids","volume":"229","author":"Anchan","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20261119","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejogrb.2013.08.036","article-title":"Measurement of uterine fibroid volume: a comparative accuracy and validation of methods study","volume":"171","author":"Quinn","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R14-20261119","first-page":"86","article-title":"Estimation of nongravid uterine volume based on a nomogram of gravid uterine volume: its value in gynecologic uterine abnormalities","volume":"72","author":"Goldstein","year":"1988","journal-title":"Obstet Gynecol"},{"key":"R15-20261119","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jval.2011.07.007","article-title":"Further validation of the Uterine Fibroid Symptom and Quality-of-Life questionnaire","volume":"15","author":"Coyne","year":"2012","journal-title":"Value Health"},{"key":"R16-20261119","first-page":"290","article-title":"The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R17-20261119","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36), I: conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"R18-20261119","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1148\/radiol.2463070260","article-title":"Symptomatic uterine fibroids: treatment with uterine artery embolization or hysterectomy\u2014results from the randomized clinical Embolisation Versus Hysterectomy (EMMY) trial","volume":"246","author":"Hehenkamp","year":"2008","journal-title":"Radiology"},{"key":"R19-20261119","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36)","volume":"31","author":"McHorney","year":"1993","journal-title":"Med Care"},{"key":"R21-20261119","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","article-title":"Balancing covariates via propensity score weighting","volume":"113","author":"Li","year":"2018","journal-title":"J Am Stat Assoc"},{"key":"R23-20261119","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/gyn.2020.0021","article-title":"Three-year results of the SONATA pivotal trial of transcervical fibroid ablation for symptomatic uterine myomata","volume":"36","author":"Lukes","year":"2020","journal-title":"J Gynecol Surg"},{"key":"R24-20261119","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/1933719114556481","article-title":"Treatment of uterine myomas by radiofrequency thermal ablation: a 10-year retrospective cohort study","volume":"22","author":"Yin","year":"2015","journal-title":"Reprod Sci"},{"key":"R25-20261119","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/CEOR.S155038","article-title":"Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada","volume":"10","author":"Rattray","year":"2018","journal-title":"Clinicoecon Outcomes Res"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:01:03Z","timestamp":1795122063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006432","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"2026-04-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}